Aristotle Capital Boston Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$12M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$9.41M |
| 3 |
iShares Russell 2000 Value ETF
IWN
|
+$4.96M |
| 4 |
iShares Russell 2000 Growth ETF
IWO
|
+$4.18M |
| 5 |
RPC Inc
RES
|
+$3.35M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMSG
Amsurg Corp
AMSG
|
+$10.2M |
| 2 |
FFWM
First Foundation Inc
FFWM
|
+$3.16M |
| 3 |
Wabash National
WNC
|
+$1.35M |
| 4 |
ArcBest
ARCB
|
+$758K |
| 5 |
MODV
ModivCare
MODV
|
+$469K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.94% |
| 2 | Technology | 17.32% |
| 3 | Financials | 16.14% |
| 4 | Healthcare | 11.97% |
| 5 | Consumer Discretionary | 7.7% |
Similar funds
Aristotle Capital Boston's Q4 2016 Portfolio in Review
As of Q4 2016, Aristotle Capital Boston held 130 positions worth $730M, up 30% from $561M the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Aristotle Capital Boston deployed $111M of net new capital in Q4 2016, opening 27 new positions and adding to 88 existing holdings. Its largest new stake was Envision Healthcare Holdings Inc: 184,286 shares worth $11.7M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 21% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Wabash National, an estimated $1.35M trimmed.
- Aristotle Capital Boston's largest Q4 2016 buy was Envision Healthcare Holdings Inc: 184,286 shares worth $11.7M.
- Aristotle Capital Boston added most to iShares Russell 2000 ETF in Q4 2016, an estimated $9.41M increase.
- Aristotle Capital Boston's biggest Q4 2016 reduction was Wabash National, cutting an estimated $1.35M.
- Aristotle Capital Boston fully exited Amsurg Corp in Q4 2016, selling an estimated $10.2M.
- Aristotle Capital Boston's ten largest holdings make up 19% of its $730M portfolio in Q4 2016.
- Aristotle Capital Boston opened 27 new positions and closed 2 in Q4 2016.
- Aristotle Capital Boston's portfolio value rose 30% quarter-over-quarter to $730M.
Based on Aristotle Capital Boston's 13F filing for Q4 2016, filed 14 Feb 2017.